St. Luke's Episcopal Health System

Reimbursement changes, an inadequate method of treatment, and delivery model that can't scale up to meet a growing patient population have opened the door to innovation in an industry traditionally re

by Cheri Thompson Vascular Closure Devices Effective, but Underused, Following PCI A large study suggests patients who undergo percutaneous coronary intervention (PCI) procedures have substantially r

When we first became acquainted with Houston’s MicroMed Cardiovascular Inc. (then known as MicroMed Technology) in 1998, the start-up sought to bring left ventricular assist devices (LVADs) into t

The road to heart failure is on a steady decline. Patients get progressively worse as time goes by and that means they need different therapeutic options depending on where they are in their journey.